Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Pinato

Showing results (51-60 of 286) with videos related to

Pageof 29
Sort By:
Hepatology (Baltimore, Md.)|December 28, 2020
Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular CarcinomaDavid J Pinato, Petros Fessas, Gonzalo Sapisochin, et al.
F1000Research|July 13, 2019
Recent advances in HIV-associated Kaposi sarcomaAlessia Dalla Pria, David J Pinato, Margherita Bracchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2022
Breaking the Child-Pugh Dogma in Hepatocellular CarcinomaPhilip James Johnson, David J Pinato, Anton Kalyuzhnyy, et al.
Journal of Clinical Pathology|October 23, 2012
CD24: a potential new marker in differentiating malignant mesothelioma from pulmonary adenocarcinomaDavid J Pinato, Paul Nya, Rohini Sharma, et al.
Gut|April 29, 2025
Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunctionMatthias Pinter, Claudia A M Fulgenzi, David J Pinato, et al.
Journal of Clinical Medicine|October 21, 2020
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer ImmunotherapyLeila Motedayen Aval, James E Pease, Rohini Sharma, et al.
International Journal of Cancer|November 6, 2024
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trialKazuki Takada, Shinkichi Takamori, Mototsugu Shimokawa, et al.
JHEP Reports : Innovation in Hepatology|September 10, 2021
ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinomaCoskun O Demirtas, Antonio D'Alessio, Lorenza Rimassa, et al.
Journal of Clinical Pathology|November 4, 2017
PD-L1Anthousa Kythreotou, Abdul Siddique, Francesco A Mauri, et al.
The Lancet. Oncology|September 29, 2022
COSMIC-312: mounting immunotherapy enigmas for hepatocellular carcinomaGiuseppe Cabibbo, Ciro Celsa, Antonio D'Alessio, et al.
Pageof 29

Showing results (51-60 of 286) with videos related to

Sort By:
Pageof 29
Hepatology (Baltimore, Md.)|December 28, 2020
Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular CarcinomaDavid J Pinato, Petros Fessas, Gonzalo Sapisochin, et al.
F1000Research|July 13, 2019
Recent advances in HIV-associated Kaposi sarcomaAlessia Dalla Pria, David J Pinato, Margherita Bracchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2022
Breaking the Child-Pugh Dogma in Hepatocellular CarcinomaPhilip James Johnson, David J Pinato, Anton Kalyuzhnyy, et al.
Journal of Clinical Pathology|October 23, 2012
CD24: a potential new marker in differentiating malignant mesothelioma from pulmonary adenocarcinomaDavid J Pinato, Paul Nya, Rohini Sharma, et al.
Gut|April 29, 2025
Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunctionMatthias Pinter, Claudia A M Fulgenzi, David J Pinato, et al.
Journal of Clinical Medicine|October 21, 2020
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer ImmunotherapyLeila Motedayen Aval, James E Pease, Rohini Sharma, et al.
International Journal of Cancer|November 6, 2024
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trialKazuki Takada, Shinkichi Takamori, Mototsugu Shimokawa, et al.
JHEP Reports : Innovation in Hepatology|September 10, 2021
ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinomaCoskun O Demirtas, Antonio D'Alessio, Lorenza Rimassa, et al.
Journal of Clinical Pathology|November 4, 2017
PD-L1Anthousa Kythreotou, Abdul Siddique, Francesco A Mauri, et al.
The Lancet. Oncology|September 29, 2022
COSMIC-312: mounting immunotherapy enigmas for hepatocellular carcinomaGiuseppe Cabibbo, Ciro Celsa, Antonio D'Alessio, et al.
Pageof 29